<quotes>
[1] "Elisadek et al. now describe the synthesis and characterization of the peptide-conjugate prodrug of doxorubicin."
[2] "This prodrug is stable and has anti-proliferative effects in a PSA-specific prostate cancer cell line, making it a worthy candidate for further preclinical studies."
</quotes>

<EnglishVersionAnswer>
The synthesis and characterization of the peptide-conjugate prodrug of doxorubicin, as described by Elisadek et al., demonstrate its stability and anti-proliferative effects in a PSA-specific prostate cancer cell line. This makes it a promising candidate for further preclinical studies in the context of targeted cancer therapy.
</EnglishVersionAnswer>

<ChineseVersionAnswer>
Elisadek等人现在描述了多柔比星肽偶联前药的合成和表征。该前药在PSA特异性前列腺癌细胞系中表现出稳定性与抗增殖作用，使其成为进一步进行临床前研究的有前景候选药物，在靶向癌症治疗的背景下具有重要意义。
</ChineseVersionAnswer>
